Načítá se...
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
<p>Abstract</p> <p>Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically selected BRCA1-carriers for the neoadjuvant treatment and used monotherapy by cisplatin instead of conventional schemes. Although the TNM staging of the recruited patients...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2009-04-01
|
| Edice: | Hereditary Cancer in Clinical Practice |
| On-line přístup: | http://www.hccpjournal.com/content/7/1/8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|